|
MOP
& Operating Policies
Network
Directory
Email
Alias Lists
Bibliography
Training
Budget
Guidance
Regulatory
Resources
QA/QC
Corner
Network
Evaluation
Human
Subject Protection Resources
Meeting
& Call Minutes
Meeting
& Call Calendars
Newsletter
Network
Reports
Public
Data Sets
Network
Templates
Acronym
List
Other
Links
|
|
PrEP Consultative Meeting
Atlanta, GA
May 2, 2008
Fifty-five
colleagues from multiple research disciplines participated in a one-day
meeting on May 2, 2008 to identify key scientific questions to be
addressed in future prevention research on pre-exposure prophylaxis (PrEP)
for prevention of HIV. Participants represented the scientific,
advocacy, pharmaceutical and funding communities. The meeting was hosted
and organized by the HIV Prevention Trials Network with support from a
Cooperative Agreement from the NIH/NIAID.
The six
objectives of this consultative meeting were:
-
To provide an update on
effectiveness trials;
-
To review mouse and
sub-human primate data from the past year, with particular emphasis
on intermittent dosing;
-
To review the
pharmacology data for the various drugs and formulations used for
PrEP;
-
To determine what study
designs should be considered for feasibility studies (adherence/PK
measures in different populations, evaluating sexual behavior
patterns);
-
To assess surveillance
data for HIV resistance; and
-
To discuss new drugs or
combinations to consider in “next generation” PrEP.
Summary
Presentations
Presentations are available in pdf format
only. Click on a hyperlinked title to view or download individual presentations.
Presenters and authors
retain copyright over these presentations and requests for use should be
directed accordingly.
|
|
